Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01879891 · ClinicalTrials.gov registry record · NA

Exercise Intensity, Metabolic Rate and Insulin Sensitivity

A NA study of Healthy Women, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT01879891: Completed NA study of Healthy Women, sponsored by University of Alabama at Birmingham.

NCT01879891 is a NA study of Healthy Women that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 44 participants, below the 53-participant average among 4 other Healthy Women trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01879891, a NA study of Healthy Women, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The primary goal is to test the hypothesis high interval exercise increases energy expenditure and Insulin sensitivity more than 2 days of rest or moderate intensity exercise cumulatively over 23 hours during and following the exercise. Secondary goals are to evaluate exercise difficulty during moderate intensity exercise and high interval exercise as well as difficulty of activities of daily living and free living physical activity following rest, moderate intensity exercise and high interval exercise. A secondary study is designed to evaluate potential mechanism. Hypotheses are that changes in muscle lipid metabolism, mitochondrial function, fat and cellular insulin signals will be increased following the high intensity interval exercise. In addition, these changes will be related to changes in insulin sensitivity and increases in protein metabolism and muscle damage.

Primary Outcome

To test the hypothesis that high interval exercise increases energy expenditure and Insulin sensitivity more than 2 days of rest or moderate intensity exercise cumulatively over 23 hours during and following the exercise

Conditions Studied

Interventions

  • OTHER Aerobic

Study Locations (1)

Alabama

  • UAB - Birmingham

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 1995-05
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT01879891 record still lists

NCT01879891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 53-participant average among 4 other Healthy Women trials with a reported enrollment target (17% lower).

The record links to 1 condition, with Healthy Women appearing as the primary indexed condition, and to 1 intervention - of which Aerobic is the first listed.

NCT01879891 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT01879891 about?

NCT01879891 is a clinical study titled "Exercise Intensity, Metabolic Rate and Insulin Sensitivity". The primary goal is to test the hypothesis high interval exercise increases energy expenditure and Insulin sensitivity more than 2 days of rest or moderate intensity exercise cumulatively over 23 hours during and following the exercise. Secondary goals are to evaluate exercise difficulty during mode...

What is the current status of trial NCT01879891?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 1995-05.

What conditions does trial NCT01879891 study?

This clinical trial studies the following conditions: Healthy Women.

What interventions are being tested in trial NCT01879891?

The interventions under investigation include: Aerobic (OTHER).

Who is sponsoring clinical trial NCT01879891?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01879891 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Women

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01879891, the US trial registry maintained by the National Library of Medicine. NCT01879891 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.